Sangamo Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Hello, everyone. This is Zeeshan Merchant from Morgan Stanley. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you're a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. This session is for the fireside chat for Sangamo. With me today, I am joined by CEO, Sandy Macrae.
And with that, I will turn it over to Sandy to briefly introduce the company.
Good morning, Zeeshan, and good morning, everyone. It's a pleasure to be with you. I joined Sangamo in 2016, and Sangamo is a fascinating company. It truly is a leading genomic medicine company. And we have programs in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |